In July 2022, Guzman was promoted to the firm’s partnership in an off-cycle promotion (a move that the firm has not made in over 20 years). The fashion in which Guzman was promoted exemplifies the valued contributions that she brings to Duane Morris.

Guzman has counseled several life sciences companies through exciting inflection points over the past few years, including: the representation of a biopharmaceutical company based in Malvern, Pennsylvania, developing next-generation antibiotics in several financing transactions, including a Series C Preferred Stock Financing; a medical device startup, also based in Malvern, Pennsylvania, in its Series A Preferred Stock financing, as well as other strategic initiatives; and a pharmaceutical company focusing on concentration disorders of the kidney, in its initial corporate structuring and capitalization.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]